Prof. Marc Achen
Honorary
The Sir Peter MacCallum Department of Oncology
142 Scholarly works
3 Projects
HIGHLIGHTS
2020
Research Grant
A NOVEL THERAPEUTIC STRATEGY FOR LYMPHOEDEMA
2019
Journal article
Evolutionary Differences in the Vegf/Vegfr Code Reveal Organotypic Roles for the Endothelial Cell Receptor Kdr in Developmental Lymphangiogenesis
DOI: 10.1016/j.celrep.2019.07.0552019
Journal article
CCL27/CCL28-CCR10 Chemokine Signaling Mediates Migration of Lymphatic Endothelial Cells
DOI: 10.1158/0008-5472.CAN-18-18582019
Journal article
Modulation of Immunity by Lymphatic Dysfunction in Lymphedema
DOI: 10.3389/fimmu.2019.000762016
Journal article
Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D
DOI: 10.1074/jbc.M116.7368012014
Research Grant
LYMPHATIC BIOLOGY IN HUMAN DISEASE
2013
Journal article
Vascular Endothelial Growth Factor-d Modulates Caliber and Function of Initial Lymphatics in the Dermis
DOI: 10.1038/jid.2013.83
RECENT SCHOLARLY WORKS
2018
Journal article
The evolving role of lymphatics in cancer metastasis
DOI: 10.1016/j.coi.2018.04.0082018
Journal article
Exit Stage Left: A Tumor Cell's Journey from Lymph Node to Beyond
DOI: 10.1016/j.trecan.2018.05.0072018
Conference Proceedings
A kinome-wide CRISPR screen reveals BET inhibition-associated endothelial cell resistance to anti-angiogenic therapy
DOI: 10.1158/1538-7445.AM2018-12018
Journal article
Emerging Roles for VEGF-D in Human Disease
DOI: 10.3390/biom80100012017
Journal article
Genome-wide functional analysis reveals central signaling regulators of lymphatic endothelial cell migration and remodeling
DOI: 10.1126/scisignal.aal29872017
Journal article
Data Descriptor: Systematic high-content genome-wide RNAi screens of endothelial cell migration and morphology
DOI: 10.1038/sdata.2017.92017
Journal article
Vegfd modulates both angiogenesis and lymphangiogenesis during zebrafish embryonic development
DOI: 10.1242/dev.1469692017
Journal article
The fibrinolysis inhibitor alpha(2)-antiplasmin restricts lymphatic remodelling and metastasis in a mouse model of cancer
DOI: 10.1080/08977194.2017.1349765